InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Francisco David, 首席财务官. Director active across 1 company, notably Organogenesis Holdings Inc.. In total, 10 disclosures have been recorded. History available since 15 February 2022. The latest transaction was filed on 18 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Francisco David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
44,040 股0Class A Common StockSEC:0002064832-26-000088:0
195,312 股0Class A Common StockSEC:0002064832-26-000060:0
3,898 股@ US$3.739.5% 占其流量Class A Common StockSEC:0002064832-26-000031:0
165,156 股0Class A Common StockSEC:0001062993-25-003224:0
11,765 股@ US$3.7035.8% 占其流量Class A Common StockSEC:0001062993-25-002931:0
160,350 股0Class A Common StockSEC:0001062993-24-004314:0
18,966 股@ US$3.6856.0% 占其流量Class A Common StockSEC:0001062993-24-003761:0
242,508 股0Class A Common StockSEC:0001062993-23-004888:0
3,506 股@ US$2.928.2% 占其流量Class A Common StockSEC:0001062993-23-004055:0
40,348 股0Class A Common StockSEC:0001062993-22-004796:0
10 条申报中的 10 条
About Francisco David
Francisco David is Chief Financial Officer at Organogenesis Holdings Inc. He has 10 filings in total, and across the sampled recent filings from 2022-02-17 to 2026-03-03, both buy and sell amounts are 0 EUR, with the dominant transaction nature shown as Attribution.
